ERS Genomics

1 follower


ERS Genomics was formed to commercialize the foundational CRISPR-Cas9 intellectual property held by co-inventor, co-owner, and Nobel Prize-winner Dr. Emmanuelle Charpentier. Licenses are available in multiple fields of use.

Industries

Headquarters

Employees

Links

Org chart

Eric Rhodes

Collapse
Jon Kratochvil
VP of Business Development & Licensing, North America
Michael Arciero
VP of IP & Commercial Development
Ralph Vogelsang
Senior Director of Business Development & Licensing
Paul Carter
Senior Director of Business Development & Licensing, North America
Cillian McGorman
Business Development & Product Manager
Janice Valentine
Executive Assistant